Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.
The type of guidance that might help me can be found in a paper that was published in 2022 on PSNet, the Patient Safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback